HT007 Activators
HT007 include a range of compounds that can influence various signaling pathways and cellular processes, ultimately leading to the activation of this protein. Forskolin and isoproterenol, for example, both act to increase the levels of cyclic AMP (cAMP) within cells. Forskolin accomplishes this by directly activating adenylyl cyclase, while isoproterenol, a beta-adrenergic receptor agonist, stimulates the same enzyme through receptor-mediated processes. In both scenarios, the elevation of cAMP facilitates the activation of HT007, assuming it is cAMP-responsive. Dibutyryl-cAMP, a cell-permeable analog of cAMP, can directly activate HT007 through similar pathways, bypassing the membrane receptors. IBMX further contributes to this activation by inhibiting phosphodiesterases and thus preventing the degradation of cAMP, leading to its accumulation and sustained activation of HT007.
cAMP-related mechanisms, calcium signaling plays a significant role in the activation of HT007. Compounds such as ionomycin and A23187 are calcium ionophores that elevate intracellular calcium levels, which can activate HT007 if it is responsive to such signals. Thapsigargin, by inhibiting the SERCA pump, disrupts calcium homeostasis, causing a rise in cytosolic calcium that could similarly lead to HT007 activation. Moreover, bradykinin triggers a cascade that results in increased intracellular calcium via the bradykinin B2 receptor pathway. PMA, an activator of protein kinase C, can activate HT007 if it is regulated by or downstream of PKC. Anisomycin, through its role in activating stress response pathways like the MAPK pathway, can also lead to the activation of HT007 if it is a part of this signaling cascade. Lastly, hydrogen peroxide, as a reactive oxygen species, can influence the activity of HT007 by modulating redox-sensitive signaling pathways. The activation profile of HT007 is thus shaped by a diverse array of molecular signals that converge on and modulate its activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) is a potent activator of protein kinase C (PKC). PKC activation leads to downstream effects on signal transduction pathways. Assuming HT007 is a substrate for PKC or is otherwise regulated downstream of PKC, PMA activation of PKC would result in the activation of HT007. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can activate various calcium-dependent proteins and pathways. If HT007 is activated by calcium signaling, then ionomycin's effect on increasing intracellular calcium concentrations would lead to the activation of HT007. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a synthetic catecholamine that acts as an agonist of beta-adrenergic receptors. Upon binding, it stimulates adenylate cyclase activity, increasing cAMP production. If HT007's activity is regulated by cAMP or downstream of beta-adrenergic receptors, the increased cAMP from isoproterenol stimulation would activate HT007. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that facilitates the increase of intracellular calcium concentration, similar to Ionomycin. If HT007 is a calcium-dependent protein, the increased intracellular calcium mediated by A23187 would activate HT007. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
3-Isobutyl-1-methylxanthine (IBMX) is a nonspecific inhibitor of phosphodiesterases, which degrade cAMP and cGMP. By preventing the breakdown of these cyclic nucleotides, IBMX leads to their accumulation. If HT007 is regulated by cAMP or cGMP, the increase in these nucleotides due to IBMX would activate HT007. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is an inhibitor of protein synthesis and also a JNK activator. However, it can activate stress response pathways such as the MAPK pathway. Activation of MAPK can lead to the activation of numerous downstream proteins. If HT007 is regulated directly by MAPK signaling, then anisomycin-induced activation of this pathway would activate HT007. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) pump inhibitor, leading to an increase in cytosolic calcium levels. If HT007 activity is modulated by calcium levels or is part of a signaling pathway affected by calcium, the disruption of calcium homeostasis by thapsigargin would activate HT007. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that can activate cAMP-dependent pathways. If HT007 is responsive to cAMP signaling, then the introduction of dibutyryl-cAMP would bypass the cell membrane and directly activate HT007 through cAMP-dependent pathways. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin is a peptide that activates the bradykinin B2 receptor, which can lead to the activation of phospholipase C and increase inositol trisphosphate (IP3) and diacylglycerol (DAG), leading to the release of calcium from intracellular stores. If HT007 is activated by calcium or downstream of the bradykinin B2 receptor signaling, then bradykinin would activate HT007. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast is an inhibitor of phosphodiesterase 5 (PDE5), which specifically increases levels of cGMP by preventing its breakdown. If HT007 functions downstream of or is regulated by cGMP-dependent pathways, the inhibition of PDE5 by Zaprinast, leading to increased cGMP levels, would activate HT007. | ||||||